Drug-Eluting Contact Lens for Eye Disease Treatment ID: 2015-043
A novel drug-delivery system using silicone hydrogel contact lenses for treating eye diseases, particularly glaucoma.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology involves a breakthrough method of loading hydrophobic drugs into silicone hydrogel contact lenses using n-propanol as a solvent, offering a more efficient and faster drug-loading process. Designed to provide a continuous and controlled release of medication directly to the eye, this invention aims to overcome the limitations of traditional eye drop and ointment treatments by ensuring consistent exposure to therapeutic drug concentrations, particularly beneficial for glaucoma patients.
Key Advantages
- Efficient and fast drug-loading process
- Continuous and controlled drug release directly to the eye
- Overcomes limitations of conventional eye drop and ointment treatments
- Potential for application in treating a wide range of eye diseases
Problems Addressed
- Inefficient drug delivery and wastage common with eye drops and ointments
- Uncontrolled drug release leading to subtherapeutic or toxic concentrations
- Limited treatment options for various eye diseases
Market Applications
- Treatment of glaucoma and other eye diseases
- Potential adaptation for other medical treatments beyond ophthalmology
- Global healthcare markets, with a focus on Europe and Asia
Additional Information
Technology ID: 2015-043
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report